{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:07:07Z","timestamp":1791814027618,"version":"4.3.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Cognitive symptoms are reported commonly throughout all phases of a migraine; however, there is a paucity of objective cognitive profiling. Previous studies have been limited by practice effect, and variable populations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Participants completed 1 month of daily testing with a computerised cognitive battery involving a simple reaction (SRT), choice reaction (CRT) and a working memory test (WM). Results were correlated with their diary to identify interictal scores, and scores during each phase of a migraine, and non-migraine headache days.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 16 patients with episodic migraine participated. During the headache phase of a migraine, responses to SRT, CRT and WM tasks were significantly slower and less accurate than interictally. During the postdrome, WM task performance was slower and less accurate. Non-migraine headache days were not associated with significant change.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The headache and postdromal phase of a migraine day was associated with objective evidence of cognitive dysfunction in patients with episodic migraine.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10072-024-07520-w","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T05:01:31Z","timestamp":1712898091000},"page":"4445-4449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cognitive assessment during the phases of a spontaneous migraine: a prospective cohort study"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4833-5507","authenticated-orcid":false,"given":"Jason C.","family":"Ray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Darby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Butzkueven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjit S.","family":"Matharu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elspeth J.","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,12]]},"reference":[{"key":"7520_CR1","doi-asserted-by":"crossref","unstructured":"Gil-Gouveia R, Oliveira AG, Martins IP (2016) The impact of cognitive symptoms on migraine attack-related disability. Cephalalgia [Internet] 36(5):422\u201330. Available from: http:\/\/journals.sagepub.com\/doi\/10.1177\/0333102415604471.\u00a0Accessed 26 Jun 2023","DOI":"10.1177\/0333102415604471"},{"key":"7520_CR2","doi-asserted-by":"crossref","unstructured":"Gil-Gouveia R, Martins IP (2018) Clinical description of attack-related cognitive symptoms in migraine: a systematic review. Cephalalgia [Internet] 38(7):1335\u201350. Available from: http:\/\/journals.sagepub.com\/doi\/10.1177\/0333102417728250. Accessed 26 Jun 2023","DOI":"10.1177\/0333102417728250"},{"issue":"1","key":"7520_CR3","doi-asserted-by":"publisher","first-page":"E137","DOI":"10.36076\/ppj\/2016.19.E137","volume":"19","author":"R Gil-Gouveia","year":"2016","unstructured":"Gil-Gouveia R, Oliveira AG, Martins IP (2016) Subjective cognitive symptoms during a migraine attack: a prospective study of a clinic-based sample. Pain Phys 19(1):E137\u2013E150","journal-title":"Pain Phys"},{"key":"7520_CR4","doi-asserted-by":"crossref","unstructured":"Alenius M, Koskinen S, Hallikainen I et al (2019) Cognitive performance among cognitively healthy adults aged 30\u2013100 years. Dement Geriatr Cogn Dis Extra [Internet] 9(1):11\u201323. Available from: https:\/\/www.karger.com\/Article\/FullText\/495657. Accessed 26 Jun 2023","DOI":"10.1159\/000495657"},{"key":"7520_CR5","doi-asserted-by":"crossref","unstructured":"McCaffrey RJ, Ortega A, Orsillo SM et al (1992) Practice effects in repeated neuropsychological assessments. Clin Neuropsychol [Internet] 6(1):32\u201342. Available from: http:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/13854049208404115.\u00a0Accessed 26 Jun 2023","DOI":"10.1080\/13854049208404115"},{"key":"7520_CR6","doi-asserted-by":"crossref","unstructured":"Bartels C, Wegrzyn M, Wiedl A et al (2010) Practice effects in healthy adults: a longitudinal study on frequent repetitive cognitive testing. BMC Neurosci [Internet] 11(1):118. Available from: https:\/\/bmcneurosci.biomedcentral.com\/articles\/10.1186\/1471-2202-11-118.\u00a0Accessed 26 Jun 2023","DOI":"10.1186\/1471-2202-11-118"},{"key":"7520_CR7","doi-asserted-by":"crossref","unstructured":"Gil-Gouveia R, Oliveira AG, Martins IP (2015) Cognitive dysfunction during migraine attacks: a study on migraine without aura. Cephalalgia [Internet] 35(8):662\u201374. Available from: http:\/\/journals.sagepub.com\/doi\/10.1177\/0333102414553823.\u00a0Accessed 26 Jun 2023","DOI":"10.1177\/0333102414553823"},{"key":"7520_CR8","doi-asserted-by":"crossref","unstructured":"Mulder E, Linssen W, Passchier J et al (1999) Interictal and postictal cognitive changes in migraine. Cephalalgia [Internet] 19(6):557\u201365. Available from: http:\/\/journals.sagepub.com\/doi\/10.1046\/j.1468-2982.1999.019006557.x.\u00a0Accessed 26 Jun 2023","DOI":"10.1046\/j.1468-2982.1999.019006557.x"},{"key":"7520_CR9","doi-asserted-by":"crossref","unstructured":"Meyer JS, Thornby J, Crawford K et al (2000) Reversible cognitive decline accompanies migraine and cluster headaches. Headache J Head Face Pain [Internet] 40(8):638\u201346. Available from: http:\/\/doi.wiley.com\/10.1046\/j.1526-4610.2000.040008638.x.\u00a0Accessed 26 Jun 2023","DOI":"10.1046\/j.1526-4610.2000.040008638.x"},{"key":"7520_CR10","doi-asserted-by":"crossref","unstructured":"Merlo D, Darby D, Kalincik T et al (2019) The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis. Ther Adv Neurol Disord [Internet] 12:175628641985918. Available from: http:\/\/journals.sagepub.com\/doi\/10.1177\/1756286419859183.\u00a0Accessed 26 Jun 2023","DOI":"10.1177\/1756286419859183"},{"key":"7520_CR11","doi-asserted-by":"crossref","unstructured":"Ho S, Darby D, Bear N (2020) Cognitive effects of onabotulinumtoxinA in chronic migraine. BMJ Neurol Open [Internet] 2(1):e000014. Available from: https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2019-000014.\u00a0Accessed 26 Jun 2023","DOI":"10.1136\/bmjno-2019-000014"},{"key":"7520_CR12","doi-asserted-by":"crossref","unstructured":"Yam C, Merlo D, Stankovich J et al (2020) The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosis. Mult Scler Relat Disord [Internet] 43:102212. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034820302881.\u00a0Accessed 26 Jun 2023","DOI":"10.1016\/j.msard.2020.102212"},{"key":"7520_CR13","doi-asserted-by":"crossref","unstructured":"Gil-Gouveia R, Martins IP (2019) Cognition and cognitive impairment in migraine. Curr Pain Headache Rep 23(11)","DOI":"10.1007\/s11916-019-0824-7"},{"key":"7520_CR14","doi-asserted-by":"crossref","unstructured":"Moulton EA, Becerra L, Maleki N et al (2011) Painful heat reveals hyperexcitability of the temporal pole in interictal and ictal migraine states. Cereb Cortex [Internet] 21(2):435\u201348. Available from: https:\/\/academic.oup.com\/cercor\/article-lookup\/doi\/10.1093\/cercor\/bhq109.\u00a0Accessed 26 Jun 2023","DOI":"10.1093\/cercor\/bhq109"},{"key":"7520_CR15","doi-asserted-by":"crossref","unstructured":"de Tommaso M, Valeriani M, Guido M et al (2003) Abnormal brain processing of cutaneous pain in patients with chronic migraine. Pain [Internet] 101(1):25\u201332. Available from: https:\/\/journals.lww.com\/00006396-200301000-00004.\u00a0Accessed 26 Jun 2023","DOI":"10.1016\/S0304-3959(02)00299-3"},{"key":"7520_CR16","doi-asserted-by":"crossref","unstructured":"Mathur VA, Khan SA, Keaser ML et al (2015) Altered cognition-related brain activity and interactions with acute pain in migraine. NeuroImage Clin [Internet] 7:347\u201358. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213158215000042.\u00a0Accessed 26 Jun 2023","DOI":"10.1016\/j.nicl.2015.01.003"},{"key":"7520_CR17","doi-asserted-by":"crossref","unstructured":"Tortorella P, Rocca MA, Colombo B et al (2006) Assessment of MRI abnormalities of the brainstem from patients with migraine and multiple sclerosis. J Neurol Sci [Internet] 244(1\u20132):137\u201341. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X06000372.\u00a0Accessed 26 Jun 2023","DOI":"10.1016\/j.jns.2006.01.015"},{"key":"7520_CR18","doi-asserted-by":"crossref","unstructured":"Tolner EA, Chen S-P, Eikermann-Haerter K (2019) Current understanding of cortical structure and function in migraine. Cephalalgia [Internet] 39(13):1683\u201399. Available from: http:\/\/journals.sagepub.com\/doi\/10.1177\/0333102419840643.\u00a0Accessed 26 Jun 2023","DOI":"10.1177\/0333102419840643"},{"key":"7520_CR19","doi-asserted-by":"crossref","unstructured":"Proserpio P, Agostoni EC (2020) Sleep and migraine. Neurol Sci [Internet] 41(S2):437\u20138. Available from: https:\/\/link.springer.com\/10.1007\/s10072-020-04644-7.\u00a0Accessed 26 Jun 2023","DOI":"10.1007\/s10072-020-04644-7"},{"key":"7520_CR20","doi-asserted-by":"crossref","unstructured":"Duan S, Ren Z, Xia H et al (2022) Association between sleep quality, migraine and migraine burden. Front Neurol [Internet] 13. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.955298\/full.\u00a0Accessed 26 Jun 2023","DOI":"10.3389\/fneur.2022.955298"},{"key":"7520_CR21","doi-asserted-by":"crossref","unstructured":"Gildner TE, Liebert MA, Kowal P et al (2014) Associations between sleep duration, sleep quality, and cognitive test performance among older adults from six middle income countries: results from the Study on Global Ageing and Adult Health (SAGE). J Clin Sleep Med [Internet] 10(06):613\u201321. Available from: http:\/\/jcsm.aasm.org\/doi\/10.5664\/jcsm.3782.\u00a0Accessed 26 Jun 2023","DOI":"10.5664\/jcsm.3782"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07520-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-024-07520-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07520-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T10:32:40Z","timestamp":1723026760000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-024-07520-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,12]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["7520"],"URL":"https:\/\/doi.org\/10.1007\/s10072-024-07520-w","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,12]]},"assertion":[{"value":"27 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received institutional review board approval (Alfred Health HREC 153\/21). Patients provided informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Dr. Ray has received funding for educational activity from Abbvie, Novartis and Viatris. He has served on medical advisory boards for Pfizer, Viatris, and Lilly. Professor Butzkueven\u2019s institution (Monash University) received compensation for consulting, talks, and advisory\/steering board activities from Alfred Health, Biogen, Merck, Novartis, Roche and UCB; research support from Biogen, Merck, MS Research Australia, National Health and Medical Research (Australia), Medical Research Future Funds (Australia) Novartis, the Oxford Health Policy Forum, and Roche. He has received personal compensation for steering group activities from Oxford Health Policy Forum. Prof. Matharu serves on the advisory board for Allergan, Novartis, Eli Lilly, Autonomic Technologies Inc and TEVA and has received payment for the development of educational presentations from Allergan, electroCore, Eli Lilly, Novartis and TEVA. Dr. Hutton has served on advisory boards for Sanofi-Genzyme, Novartis, Teva, Eli Lilly, Allergan, Lundbeck, been involved in clinical trials sponsored by Novartis, Teva, Xalud, Cerecin, and has received payment for educational presentations from Allergan, Teva, Eli Lilly and Novartis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}